Description: Often actuarial practitioners are faced with working with data that is less than ideal. The data may be observed with gaps in it, a model may suggest variables that are observed at different frequencies, and sometimes predictive analytic results are very fragile to the inclusion or omission of just a few observations in the sample. Data, particularly big data, are often "messy" and something must be done about it. What is the actuary to do about these very practical matters? These types of questions are what this presentation is intended to address. Concerns on missing data, outliers, nonlinearity, mixed-frequency, cross-correlations are illustrated using real datasets in the Asia-Pacific countries. Some possible solutions to the messy data problems will be discussed.

Description: Papers: When Danes have only 15 years to live: Implications of linking retirement age with life expectancy – Jesus-Adrian Alvarez, Malene Kallestrup-Lamb, Ph.D., Søren Kjærgaard, James W. Vaupel, Ph.D. - University of Southern Denmark A Study into the Impact of Pre-Programed Genetic Health Risks in Retirement Planning – N.V. Subramanyan, Prudential Assurance Company Limited, Singapore

Description: In this session, morbidity and life expectancy trends are discussed. In addition, a case study in R on how to model the uncertainty associated with incidence of disability, disabled and active deaths and other terminations is presented.

Description: Telehealth enables the delivery of health care services to patients that are not in the same location as providers. Over the past decade, telehealth has been used increasingly to complement face-to-face patient encounters, and is particularly important to addressing health care needs in rural areas. Recent regulatory catalysts, particularly in the Medicare Advantage program, have served to elevate the visibility and importance of telehealth in the overall health care delivery system. Starting in 2020, Medicare Advantage plans can offer any clinically appropriate physician services through telehealth as part of the standard Medicare benefit. Network adequacy standards can also be met via telehealth providers under certain programs. This presentation will cover the basics of what constitutes telehealth, and provide tangible demonstrations of telehealth technology (simulating variations mediums through which services are delivered). We will cover the what, the why, and the where (anywhere) of telehealth in 2020.

Description: Hear from companies & consultants that early adopted VM-21 for year-end 2019. Learn from their experiences in preparing for the significant additional work required for implementation - updating models, assumptions, documentation, etc. Hear about the NAIC review and feedback (if available).

Description: The presenters will share information about: -Insights into causes of death through the use of predictive models, based on a reinsured U.S. life portfolio, using logistic regression models to understand three main causes of death: cancer, heart and external causes; -Opioid abuse is a widespread phenomenon with drug-related mortality rates rising steeply in the U.S. over the past two decades. But what does the most recent data tell U.S. about the outlook for Opioid-related mortality?; -'Deaths of despair' have been publicized as a cause for the poor performance of U.S. mortality in recent years. The presenters will be looking at the different causes under this label, their evolution and explore the drivers behind them.

Description: The speech was mainly introduced the current government long-term care insurance in China, analyzed the potential opportunities and challenges of commercial homecare insurance driven by the aging of the society and the pressure of social insurance. Briefly introduced some innovated explorations conducted by our company Fulfill Homecare in these couple of years, with some insurance companies, to bring some thoughts to the innovative insurance product design of commercial care insurance.

Description: Recently, actuaries have become more involved in formulary decisions due to high and variable pharmacy cost and utilization trends. How can actuaries and pharmaceutical manufacturers work together to better predict the market while covering key drugs? What discussions are currently taking place between manufacturers and payers? Is there value in these discussions that actuaries are missing? This presentation will provide both actuarial and manufacturer perspectives in order to create a mutual understanding that will begin to direct future conversations to benefit both stakeholders.

Description: Beginning with the 2019 Benefit Year, CMS (the Centers for Medicare and Medicaid Services) has provided guidance that allows Medicare Advantage Plan Sponsors much greater flexibility in tailoring benefits to promote clinical, care management, and financial goals. The guidance allows for a broader menu of supplemental benefits and also enables plans to target benefit enhancements to beneficiaries afflicted with specific disease states. This session explores the ramifications of the policy changes on Plan Sponsors and beneficiaries, and discusses the different ways that Plan Sponsors are taking advantage of the additional flexibility.

Description: This session at the SOA 1990 San Francisco Spring Meeting presents an overview of risk classification, what principles define a sound system, changes in underwriting due to expert system technology, and determining the value of laboratory tests.